Page last updated: 2024-09-04

moxifloxacin and gsk221149a

moxifloxacin has been researched along with gsk221149a in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(gsk221149a)
Trials
(gsk221149a)
Recent Studies (post-2010) (gsk221149a)
3,1575521,69013410

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caltabiano, S; Fossler, M; Liu, F; Stier, B1

Trials

1 trial(s) available for moxifloxacin and gsk221149a

ArticleYear
Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Clinical therapeutics, 2015, Jul-01, Volume: 37, Issue:7

    Topics: Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Healthy Volunteers; Heart; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Piperazines; Receptors, Oxytocin; Young Adult

2015